ALNY
Alnylam Pharmaceuticals Inc
Price:  
149.40 
USD
Volume:  
481,247.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Alnylam EV/EBITDA

-110.2%
Upside

As of 2024-05-19, the EV/EBITDA ratio of Alnylam Pharmaceuticals Inc (ALNY) is -134.30. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Alnylam's latest enterprise value is 19,153.79 mil USD. Alnylam's TTM EBITDA according to its financial statements is -142.62 mil USD. Dividing these 2 quantities gives us the above Alnylam EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 8.8x - 9.7x 9.2x
Forward P/E multiples 9.5x - 16.1x 12.8x
Fair Price (13.46) - (13.68) (15.18)
Upside -109.0% - -109.2% -110.2%
149.40 USD
Stock Price
(15.18) USD
Fair Price

Alnylam EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-05-17 -134.30
2024-05-16 -135.91
2024-05-15 -132.53
2024-05-14 -132.97
2024-05-13 -134.73
2024-05-10 -135.24
2024-05-09 -136.04
2024-05-08 -136.85
2024-05-07 -138.65
2024-05-06 -135.91
2024-05-03 -136.89
2024-05-02 -135.10
2024-05-01 -134.79
2024-04-30 -129.49
2024-04-29 -132.50
2024-04-26 -128.92
2024-04-25 -129.28
2024-04-24 -129.35
2024-04-23 -131.36
2024-04-22 -131.11
2024-04-19 -129.89
2024-04-18 -130.56
2024-04-17 -130.70
2024-04-16 -131.93
2024-04-15 -132.80
2024-04-12 -133.50
2024-04-11 -136.67
2024-04-10 -136.96
2024-04-09 -140.04
2024-04-08 -140.16
2024-04-05 -137.97
2024-04-04 -136.14
2024-04-03 -135.56
2024-04-02 -135.75
2024-04-01 -137.77
2024-03-28 -134.34
2024-03-27 -138.71
2024-03-26 -136.57
2024-03-25 -136.66
2024-03-22 -131.75
2024-03-21 -131.84
2024-03-20 -133.05
2024-03-19 -133.21
2024-03-18 -132.54
2024-03-15 -134.18
2024-03-14 -133.53
2024-03-13 -133.43
2024-03-12 -131.87
2024-03-11 -134.03
2024-03-08 -134.67